Sangamo Biosciences (SGMO) Misses Q2 EPS by 14c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. MSFT
3. PLTR
4. SPY
5. CSCO
6. KTOS
7. JPM
8. DT
9. AON
10. TMUS

Go back to Sangamo Biosciences (SGMO) Misses Q2 EPS by 14c

Sangamo BioSciences Reports Second Quarter 2016 Financial Results

August 3, 2016 4:03 PM EDT

RICHMOND, Calif., Aug. 3, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, today reported its second quarter 2016 financial results and updated on recent events and development timelines for its preclinical and clinical therapeutic programs.

"My mandate as CEO of Sangamo is to lead the Company in its transition from a research-focused... More